Search results
Man dies after 613-day COVID-19 infection that underwent 50 mutations
AOL· 3 days agoAccording to the study, the man, whose identity was not disclosed, suffered from a blood disorder....
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
Center for Infectious Disease Research and Policy· 1 day agoTaking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19...
COVID-19 vaccine effectiveness and fewer common side effects most important factors in whether...
Medical Xpress· 1 day agoConcerns about the common side effects of COVID-19 vaccines and their effectiveness are key to...
Engineers muffle invading pathogens with a 'molecular mask'
Phys.org· 1 day agoThe peptides that make up this gel prevent viruses such as SARS-CoV-2, which causes COVID-19, from attaching to and entering cells. Over ...
Novel Hydrogel Therapy Impedes Invading Pathogens
Technology Networks· 2 days agoThe peptides that make up this gel prevent viruses such as SARS-CoV-2, which causes COVID-19, from attaching to and entering cells. Over ...
Newly Discovered Prehistoric Snake May Be Largest To Ever Exist, Vaccine Breakthrough Could Mean...
IFLScience· 6 days agoThis week, a physicist studying the SARS-CoV-2 virus believes he’s found evidence that we’re living...
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Medical Xpress· 2 days agoResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife ...
The Covid Revisionists Are Endangering Us All
The Nation· 13 hours agoAt the same time, we’re being told we got it all wrong in our response to Covid. This “nevertheless” carries a lot of weight for Wallace-Wells, because...
Long COVID Taste Loss May Not Involve Taste Buds
MedPage Today· 3 days agoStudy attempts to untangle taste and olfactory dysfunction 1 year after infection
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga via Yahoo Finance· 13 hours agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within...